Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

sary.

Upcoming Corporate PresentationsArena is planning to present at upcoming investment and industry conferences, including:

  • Piper Jaffray 22nd Annual Health Care Conference, November 30-December 1, 2010, New York, New York
  • 29th Annual J.P. Morgan Healthcare Conference, January 10-13, 2011, San Francisco, California

  • About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is intended for weight management. Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States following FDA approval of the New Drug Application for lorcaserin.

    Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company.

    Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about BLOOM-DM, including providing support for lorcaserin's profile; addressing recommendations in the complete response letter for lorcaserin; the advancement, therapeutic indication and use, safety, efficacy, tolerability, mechanism of action, scheduling and regulatory review, approval, commercialization and potential of lorcaserin; the termination of the Ortho-McNeil-Janssen collaboration and related expectations and future activities; the therapeutic indication and use, safety, efficacy, tolerability, mechanism of action and potential of APD597 alone and in combination; the therapeutic indication and use, mechanism of action and exposures of APD916; the Eisai collaboration
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
    2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
    3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
    4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
    5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
    6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
    7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
    8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
    9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
    10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
    11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
    (Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
    (Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
    Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
    ... Research, Advocacy and New Treatments , , ... May 11 The National Organization for Rare Disorders (NORD) will honor two trailblazing ... market for rare diseases at the 2010 NORD Partners in Progress Gala at the Andrew ... , , ...
    ... , MELBOURNE, Fla. , May 11 ... Therapeutics Corporation announced today the successful launch of its ... was selected to provide cardiac monitoring equipment by CNES, ... biomedical products. Cardiomed will utilize Medicomp,s durable Decipher Holter ...
    Cached Medicine Technology:NORD to Honor Rare Disease Innovators 2NORD to Honor Rare Disease Innovators 3NORD to Honor Rare Disease Innovators 4Medicomp's Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station 2Medicomp's Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station 3
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
    (Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
    (Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
    (Date:1/22/2015)... 2015 Four years since the release of their ... with the marriage of Avasa & Matthew Love – the duo ... scheduled for release through White Swan Records on February 24, 2015. ... a sacred path available to all of us to walk out ...
    (Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
    Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
    ... survivors address issues of sexual dysfunction with their patients, ... (MGH) researchers. In their article appearing in a ... of General Internal Medicine , now available online, the ... to a survey indicated they rarely or never discussed ...
    ... continue to push for progress , WEDNESDAY, Oct. 21 ... levels,a new report shows. , A record number of vaccines ... and more than 80 new vaccines are in late-stage clinical ... by the World Health Organization, UNICEF and the World Bank. ...
    ... ... ... the new report on the state of the world,s vaccines and immunization launched by the ... exactly what the United Nations Foundation strives to achieve. As a proud ...
    ... to Support Minimally Invasive Treatment in Those With Blocked Leg ... Vascular and Interventional Radiology , FAIRFAX, Va., Oct. ... PAD) -- with healthy lifestyle changes -- remains vital to ... Journal of Vascular and Interventional Radiology. And while PAD can ...
    ... attest, high school can be filled with difficult challenges, both ... prom or filling out college applications, stress can be high ... Va., native Dalton Clark, a challenge beyond his imagination emerged ... and suddenly, typical high school hurdles paled in comparison. ...
    ... University of Nottingham say our stress levels at work peak when ... as we head towards retirement. In the first comprehensive ... carried out in Britain researchers from the Institute of Work, Health ... working lives can stay with us well into retirement. The ...
    Cached Medicine News:Health News:Sexual problems rarely addressed by internists caring for cancer survivors 2Health News:Worldwide Vaccine Availability Reaches All-Time High: Report 2Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report 2Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation on the Launch of the State of the World's Vaccines and Immunization Report 3Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 2Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 3Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 4Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 5Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 2Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 3Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 4Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 5Health News:'Inspired by Diabetes' U.S. National Contest Winners Reveal Unique Challenges but Common Resolve in the Face of Diabetes 6Health News:Older workers are the healthy 'survivors' of the workplace 2
    ... Hemaway Original attacks dried blood, tissue, ... in hard to reach places such as ... reducing the need for scrubbing. Hemaway Original ... but gentle enough to be used everyday. ...
    ... Hemaway Enzymatic Foam is the ready-to-use, pre-cleaning ... and rubber. ,Hemaway Enzymatic Foam ... prevent corrosion. It's perfect for use in ... immediately available. Getting a head start with ...
    ... Duo-Klenz is the low-foaming detergent and ... cycle of pressurized washers. Duo-Klenz ... medical and surgical instruments. Highly concentrated, ... while safely lubricating surgical instruments -- all ...
    ... Traps grip the patients finger snugly. Wrap the ... Stainless Steel Finger Trap for an extra secure ... traps create a complete upper extremity traction system ... ISI Advanced Universal K Table. Stainless Steel Finger ...
    Medicine Products: